The risk of HIV and HCV infections among injection drug users in northeast India

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 21, Issue 11, 2009, Pages 1420-1424

  Mahanta, Jagadish ^a   Borkakoty, Biswajyoti ^a   Das, Hiranya Kumar ^a   Chelleng, Pradeep Kumar ^a  

^a REGIONAL MEDICAL RESEARCH CENTRE   (India)

Author keywords

Heroin; HIV HCV co infection; Injection drug users

Indexed keywords

DEXTROPROPOXYPHENE; DIAMORPHINE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; DRUG USE; EPIDEMIC; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HEROIN DEPENDENCE; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INDIA; INFECTION RISK; INJECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PRIORITY JOURNAL; VIRUS TRANSMISSION; CROSS-SECTIONAL STUDY; PREVALENCE; SUBSTANCE ABUSE;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; INDIA; MALE; PREVALENCE; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 77649293494     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540120902862584     Document Type: Article

References (11)

1. Chandrasekaran, P., Dallabetta, G., Loo, V., Rao, S., Gayle, H., & Alexander, A. (2006). Containing HIV/ AIDS in India: The unfinished agenda. The Lancet Infectious Diseases, 6, 508-521. (Pubitemid 44160475)
2. Devi, K.S., Brajachand, N., Singh, H.L., & Singh, Y.M. (2005). Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users. The Journal of Communicable Diseases, 37(1), 73-77. (Pubitemid 43531943)
3. Jones, T.S., & Vlahov, D. (1998). Use of sterile syringes and aseptic drug preparation are important components of HIV prevention among injection drug users. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18(1), S1-S5. (Pubitemid 28304461)
4. Koeser, S., Glanz, J., & Baron, A. (2005). Drug sharing among heroin networks: Implications for HIV and hepatitis B and C prevention. AIDS and Behavior, 9(1), 27-39. (Pubitemid 40562182)
5. Kottilil, S., Jackson, J.O., & Polis, M.A. (2005). Hepatitis B & hepatitis C in HIV-infection. Indian Journal of Medical Research, 121, 424-450. (Pubitemid 40691375)
6. Li, Y., Ye, L., Peng, J.S., Wang, C.Q., Luo, G.X., Zhang, T., et al. (2007). Morphine inhibits intrahepatic interferon-a expression and enhances complete hepatitis C virus replication. Journal of Infectious Diseases, 196(5), 719-730. (Pubitemid 47293855)
7. Saha, M.K., Chakrabarti, S., Panda, S., Naik, T.N., Manna, B., Chatterjee, A., et al. (2000). Prevalence of HCV & HBV infection amongst HIV seropositive intravenous drug users & their non-injecting wives in Manipur, India. Indian Journal of Medical Research, 111, 37-39. (Pubitemid 30245596)
8. Sankaran, J.R. (2006). Current situation of HIV/AIDS in India and our response. Journal, Indian Academy of Clinical Medicine, 57(1), 13-15.
9. Soriano, V., Barreiro, P., & Nuñez, M. (2006). Management of chronic hepatitis B and C in HIV-coinfected patients. The Journal of Antimicrobial Chemotherapy, 57(5), 815-881.
10. Sulkowski, M.S., & Thomas, D.L. (2003). Hepatitis C in the HIV-infected person. Annals of Internal Medicine, 138, 197-207.
11. Wang, X., Tan, N., Douglas, S.D., Zhang, T., Wang, Y-J., & Ho, W-Z. (2005). Morphine inhibits CD8- T cellmediated, noncytolytic, anti-HIV activity in latently infected immune cells. Journal of Leukocyte Biology, 78, 772-776.